Prognostic impact of angiopoietin-2 in multiple myeloma.

Journal of cancer research and clinical oncology

Volumn 140, Issue 10, 2014, Pages 1801-1805

  Pappa, Constantina A ^a   Alexandrakis, Michael G ^b   Boula, Anna ^b   Thanasia, Aspasia ^b   Konsolas, Ioannis ^b   Alegakis, Athanasios ^b   Tsirakis, George ^b  

^a Venizelion General Hospital   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGPT1 PROTEIN, HUMAN; ANGPT2 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PLATELET-DERIVED GROWTH FACTOR AB; TUMOR MARKER;

AGED; ARTICLE; BLOOD; BONE MARROW; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; MORTALITY; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMANS; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 84908240977     PISSN: None     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1731-2     Document Type: Article

References (0)